Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resminostat plus Sorafenib in advanced HCC
NCT02400788Phase 2Completed
- Sponsor
- Yakult Honsha
- Start
- Apr 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Resminostat in hepatocellular carcinoma (HCC), sponsored by Yakult Honsha. Started Apr 2013; status: completed.
02
Drugs
Resminostat
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02400788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02400788.